ClearBridge Investments’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-4,000
| Closed | -$14K | – | 1199 |
|
|
2018
Q3 | $14K | Hold |
4,000
| – | – | ﹤0.01% | 1038 |
|
|
2018
Q2 | $15K | Sell |
4,000
-269
| -6% | -$1.31K | ﹤0.01% | 1003 |
|
|
2018
Q1 | $17K | Hold |
4,269
| – | – | ﹤0.01% | 993 |
|
|
2017
Q4 | $20K | Sell |
4,269
-4,366
| -51% | -$24.1K | ﹤0.01% | 999 |
|
|
2017
Q3 | $61K | Buy |
8,635
+517
| +6% | +$3.72K | ﹤0.01% | 822 |
|
|
2017
Q2 | $59K | Buy |
8,118
+799
| +11% | +$4.99K | ﹤0.01% | 827 |
|
|
2017
Q1 | $45K | Buy |
7,319
+3,319
| +83% | +$18.2K | ﹤0.01% | 884 |
|
|
2016
Q4 | $23K | Sell |
4,000
-1,000
| -20% | -$5.46K | ﹤0.01% | 953 |
|
|
2016
Q3 | $27K | Sell |
5,000
-1,500
| -23% | -$8.09K | ﹤0.01% | 910 |
|
|
2016
Q2 | $43K | Hold |
6,500
| – | – | ﹤0.01% | 878 |
|
|
2016
Q1 | $30K | Sell |
6,500
-3,501
| -35% | -$14K | ﹤0.01% | 914 |
|
|
2015
Q4 | $51K | Sell |
10,001
-1,000
| -9% | -$4.75K | ﹤0.01% | 917 |
|
|
2015
Q3 | $39K | Sell |
11,001
-205,944
| -95% | -$1.38M | ﹤0.01% | 984 |
|
|
2015
Q2 | $2.17M | Sell |
216,945
-1,469
| -0.7% | -$15.8K | ﹤0.01% | 661 |
|
|
2015
Q1 | $2.78M | Buy |
218,414
+64,740
| +42% | +$832K | ﹤0.01% | 659 |
|
|
2014
Q4 | $2.17M | Sell |
153,674
-4
| -0% | -$62 | ﹤0.01% | 697 |
|
|
2014
Q3 | $2.11M | Sell |
153,678
-89,059
| -37% | -$1.36M | ﹤0.01% | 701 |
|
|
2014
Q2 | $3.73M | Buy |
242,737
+117,691
| +94% | +$1.67M | ﹤0.01% | 627 |
|
|
2014
Q1 | $2.13M | Buy |
+125,046
| New | +$1.89M | ﹤0.01% | 671 |
|
ClearBridge Investments's KERX Position: Q4 2018 in Review
ClearBridge Investments sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 4,000 shares — an estimated $14K sold.
ClearBridge Investments first reported a position in KERX in Q1 2014 and held it in 19 quarters. The position peaked at $3.73M in Q2 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- ClearBridge Investments reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- ClearBridge Investments sold 4,000 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $14K.
- ClearBridge Investments first reported a position in Keryx Biopharmaceuticals Inc in Q1 2014 and held it in 19 quarters.
- ClearBridge Investments's Keryx Biopharmaceuticals Inc position peaked at $3.73M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on ClearBridge Investments's 13F filing for Q4 2018, filed 14 Feb 2019.